About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Seattle | 11,373 Studies Near You

Clinical TrialsSeattle

Clinical Trials in Seattle

Discover 11,373 clinical trials near Seattle, Washington. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 5741-5760 of 11,373 trials

CompletedSPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)This study is divided into 5 arms: 1.NCT00180479·Birmingham, Alabama and 64 others

Find Trials by Condition in Seattle

Breast Cancerin Seattle Lung Cancerin Seattle Prostate Cancerin Seattle Colorectal Cancerin Seattle Melanomain Seattle Leukemiain Seattle Lymphomain Seattle Pancreatic Cancerin Seattle Ovarian Cancerin Seattle Brain Cancerin Seattle Diabetes

Data from ClinicalTrials.govTerms

Active not recruitingTesting the Addition of Nivolumab to Standard Treatment for Patients With Metastatic or Unresectable Colorectal Cancer That Have a BRAF MutationThis phase II trial tests whether adding nivolumab to the usual treatment (encorafenib and cetuximab) works better than the usual treatment alone to shrink tumors in patients with…NCT05308446·Goodyear, Arizona and 285 others

CompletedA Study on The Safety of Administering Rituximab at A More Rapid Rate in Patients With Rheumatoid ArthritisThis study was designed to evaluate the safety of administering rituximab at a more rapid infusion rate in patients with moderate to severe rheumatoid arthritis who have had an…NCT01382940·Birmingham, Alabama and 85 others

CompletedIrinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00012389·Huntsville, Alabama and 153 others

UnknownTavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBCThis is a Phase 2, Multi-Cohort, Open-Label, Multi-Center Study.NCT03567720·Tucson, Arizona and 13 others

CompletedTosedostat in Combination With Cytarabine or Decitabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeThis study examines a new oral chemotherapy drug called tosedostat, in combination with cytarabine or decitabine.NCT01567059·Seattle, Washington

CompletedBrentuximab Vedotin and Gemcitabine Hydrochloride in Treating Younger Patients With Relapsed or Refractory Hodgkin LymphomaThis phase I/II trial studies the side effects and the best dose of brentuximab vedotin when given together with gemcitabine hydrochloride and to see how well they work in…NCT01780662·Birmingham, Alabama and 115 others

CompletedForodesine in the Treatment of Cutaneous T-Cell LymphomaThis is a Phase II, non-randomized, open-label, single-arm trial that will be conducted at up to 50 sites in North America, Europe and Australia.NCT00501735·Birmingham, Alabama and 40 others

UnknownSafety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL)The purpose of this study is to determine how well SNS01-T is tolerated by relapsed or refractory multiple myeloma, B cell lymphoma or plasma cell leukemia patients when given by…NCT01435720·Little Rock, Arkansas and 6 others

Active not recruitingA Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid TumoursThis is a first-in-human (FIH), Phase 1 open-label, multicentre dose escalation study investigating AVA6000 monotherapy administered intravenously in patients with locally…NCT04969835·New York, New York and 8 others

CompletedPhase IIb Study of Intranasal Glutathione in Parkinson's DiseaseGlutathione is an important nutrient for brain function and loss of glutathione has been implicated in Parkinson's disease.NCT02424708·Kenmore, Washington and 1 other

CompletedTreatment Protocol for the Use of Sorafenib in Patients With Advanced Renal Cell CarcinomaThis treatment protocol allows doctors to treat advanced kidney cancer with an investigational drug called sorafenib, BAY43-9006, which is being studied in clinical trials for…NCT00111020·Bessemer, Alabama and 319 others

TerminatedMultiple Doses and Regimens of Cabozantinib in Subjects With Grade IV Astrocytic Tumors in First or Second RelapseThis study was conducted in subjects with grade IV astrocytic tumors (a type of cancer that can occur in the brain or spinal cord) in first or second relapse.NCT01068782·Birmingham, Alabama and 18 others

CompletedA Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Simvastatin for at Least 4 Weeks.The primary objective is to determine the effect of WelChol tablets on serum lipids, lipoproteins, apolipoproteins, and lipoprotein particle size in patients who were stabilized…NCT00753779·Los Angeles, California and 13 others

CompletedA Randomized Study to Evaluate the Safety, Tolerability and Antiviral Activity of ABT-450, ABT-333 and ABT-072This study assessed the safety, tolerability, pharmacokinetics, and antiviral activity of multiple oral doses of ABT-450/ritonavir (r), ABT-333 (also known as dasabuvir), or…NCT01074008·Phoenix, Arizona and 25 others

Active not recruitingClinical Study for Treatment-naïve IOPD Babies to Evaluate Efficacy and Safety of ERT With Avalglucosidase AlfaThis is a single group, treatment, Phase 3, open-label study to assess efficacy, safety, pharmacokinetic (PK), pharmacodynamics (PD) of avalglucosidase alfa in treatment-naïve…NCT04910776·Stanford, California and 15 others

CompletedFilgrastim, Cladribine, Cytarabine, and Mitoxantrone With Sorafenib in Treating Patients With Newly-Diagnosed, Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeThis phase I/II trial studies the side effects and best dose of filgrastim (granulocyte colony-stimulating factor \[G-CSF\]), cladribine, cytarabine, and mitoxantrone, when given…NCT02728050·Seattle, Washington

CompletedNE3107 in Adults With Neurological Symptoms of Long COVIDLong COVID is a condition where debilitating symptoms can persist for months after a COVID-19 infection.NCT06847191·Palo Alto, California and 19 others

CompletedVeliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast CancerThis phase I trial studies the side effects and best dose of veliparib when given together with cisplatin and vinorelbine ditartrate in treating patients with breast cancer that…NCT01104259·Seattle, Washington

TerminatedSiplizumab in T1DMThis is a multicenter, Phase Ib, open-label, siplizumab dose-finding study in individuals aged 8-45 years with a Type 1 diabetes mellitus (T1DM) diagnosis. within 18 months of V0.NCT05574335·Aurora, Colorado and 4 others

PreviousPage 288 of 569Next

in Seattle

Heart Diseasein Seattle